Wolff-Parkinson-White syndrome consensus statement: Difference between revisions

	Wolff-Parkinson-White syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Wolff-Parkinson-White syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Approach
History and Symptoms
Electrocardiogram
EKG Examples
Other Diagnostic Studies
Treatment
Risk Stratification
Cardioversion
Medical Therapy
Catheter Ablation
Prophylaxis
Consensus Statement
Case Studies
Case #1
Wolff-Parkinson-White syndrome consensus statement On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Wolff-Parkinson-White syndrome consensus statement
CDC onWolff-Parkinson-White syndrome consensus statement
Wolff-Parkinson-White syndrome consensus statement in the news
Blogs on Wolff-Parkinson-White syndrome consensus statement
Directions to Hospitals Treating Deep vein thrombosis
Risk calculators and risk factors for Wolff-Parkinson-White syndrome consensus statement

Revision as of 05:40, 15 September 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Kashish Goel, M.D.

The class of Recommendation(COR)	Recommendations
1	In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over manifest pathway during exercise testing in sinus rhythm or intermittent loss of-excitation during ECG or ambulatory monitoring is useful to identify patients at low risk of rapid conduction over the pathway
2a	An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for arrhythmic events
2a	Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre- excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF
2a	Catheter ablation of the accessory pathway is reasonable in asymptomatic patients if the presence of pre-excitation precludes specific employment(such as with pilots)
2a	Observation,without further evaluation or treatment,is reasonable in asymptomatic patients with pre-excitation

@@ Line 3: / Line 3: @@
+==[[Recommendations for Management of Asymptomatic Patients With Asymptomatic pre-excitation]]==
+{| class="wikitable"
+|-
+! The class of Recommendation(COR) !! Recommendations
+|-
+|    1     || In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over
+manifest pathway during [[exercise testing]] in [[sinus rhythm]] or
+intermittent loss of-excitation during [[ECG]] or ambulatory monitoring is useful to identify patients at low risk of rapid conduction over the pathway
+|-
+| 2a || An [[EP study]] is reasonable in asymptomatic patients with pre-excitation to risk-stratify for
+arrhythmic events
+|-
+| 2a || [[Catheter ablation]] of the [[accessory pathway]] is reasonable in asymptomatic [[patients]] with pre-
+excitation if an [[EP study]] identifies a high risk of [[arrhythmic]] events, including rapidly conducting
+pre-excited [[AF]]
+|-
+| 2a || [[Catheter ablation]] of the accessory pathway is reasonable in asymptomatic patients if the presence of
+pre-excitation precludes specific employment(such as with [[pilots]])
+|-
+| 2a || Observation,without further evaluation or treatment,is reasonable in asymptomatic patients
+with pre-excitation
+|}